Treatment strategy to control blood pressure optimally in hypertensive patients

Blood Pressure

Volumn 10, Issue 2, 2001, Pages 62-73

  Waeber, B ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antihypertensive treatment; Combination therapy; Compliance; Hypertension; Quality of life; Side effects; Target blood pressure

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CLONIDINE; DIHYDROPYRIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; NIFEDIPINE; PERINDOPRIL; PLACEBO; PRAZOSIN; RENIN; SODIUM; TRIAMTERENE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; MALE; MOTIVATION; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT PLANNING;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; PATIENT COMPLIANCE;

EID: 0034937376     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050152112041     Document Type: Review

References (72)

1. Evidence-based health policy-lessons from the Global Burden of Disease Study
2. Inadequate management of blood pressure in a hypertensive population
3. Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context
4. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials
5. Predictors of cardiovascular morbidity in treated hypertension: Results from the primary preventive trial in Goteborg, Sweden
6. The key issues in preventive cardiology
7. Hypertension awareness, treatment and control in the community: Is the "rule of halves" still valid?
8. Detection and control of hypertension in the population: The United States experience
9. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
10. Blood pressure screening, management and control in England: Results from the health survey for England 1994
11. Prevalence, treatment, and control of hypertension in the French population. Data from a survey on high blood pressure in general practice, 1994
12. Current clinical practice in hypertension: The EISBERG (Evaluation and Interventions for Systolic Blood pressure Elevation-Regional and Global) project
13. Blood pressure control in a hypertension hospital clinic
14. Blood-pressure control in the hypertensive population
15. The heterogeneity of hypertension: Why doesn't every patient respond to every antihypertensive drug?
16. Treating the individual hypertensive patient: Consideration on dose, sequential monotherapy and drug combinations
17. Comparison of betaxolol with verapamil in hypertensive patients: Discrepancy between office and ambulatory blood pressures
18. Individual responses to converting enzyme inhibitors and calcium antagonists
19. Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine
20. Optimisation of antihypertensive treatment by cross-over rotation of four major classes
21. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: A study of a United Kingdom population
22. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo
23. Remembering the lessons of basic pharmacology
24. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy
25. Combination antihypertensive therapy: Does it have a role in rational therapy?
26. The importance of drug combinations for effective control of hypertension
27. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
28. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
29. Combination products as first-line pharmacotherapy
30. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide
31. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients
32. Low-dose combinations versus monotherapies in the treatment of hypertension
33. Socioeconomic factors and cardiovascular disease: A review of the literature
34. Barriers to blood pressure control
35. Cost benefit of treating hypertension
36. Physician and patient evaluation of hypertension-related risks and benefits from treatment
37. Guidelines for the Management of Hypertension
38. British Hypertension Society guidelines for hypertension management 1999: Summary
39. Managing hypertension in general practice: Can we do better?
40. Interpractice audit of diagnosis and management of hypertension in primary care: Educational intervention and review of medical records
41. Benefits and potential harm of lowering high blood pressure
42. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
43. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
44. Measurement of patient compliance and the interpretation of randomized trials
45. Clinicians and patients with hypertension: Unsettled issues about compliance
46. Randomised clinical trial of strategies for improving medication compliance in primary hypertension
47. On white-coat effects and the electronic monitoring of compliance
48. The electronic medication event monitor. Lessons for pharmacotherapy
49. Therapeutic implications of drug "holidays"
50. Discontinuation syndrome following cessation of treatment with clonidine and other antihypertensive agents
51. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers
52. The effect of withdrawing antihypertensive therapy: A review
53. Underutilization of antihypertensive drugs and associated hospitalization
54. The costs of interrupting antihypertensive drug therapy in a Medicaid population
55. Quality of life in the management of hypertension
56. Increased absenteeism from work after detection and labeling of hypertensive patients
57. Follow-up study of the use of antihypertensive drug treatment and of the population treated
58. Self-initiated modification of hypertension treatment in response to perceived problems
59. Doctors, nurses, pharmacists and patients
60. Stepped care for hypertension: Are the assumptions valid?
61. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a population-based study in the elderly
62. The effects of antihypertensive therapy on the quality of life
63. Continuation of initial antihypertensive medication after 1 year of therapy
64. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study
65. The impact of side effects on hypertension management. A Japanese survey
66. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study
67. The multilevel compliance challenge: Recommendations for a call to action. A statement for healthcare professionals
68. Does self-measurement of blood pressure improve patient compliance in hypertension?
69. Therapeutic adherence program improves compliance and lowers blood pressure
70. Impact of an electronic medication compliance aid on long-term blood pressure control
71. Improved blood pressure control by monitoring compliance with antihypertensive therapy
72. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control